DJ Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ rallied 1.11% to $67.66 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.46% to 7,666.60 and the Dow Jones Industrial Average rising 0.56% to 53,061.95.
This was the stock's third consecutive day of gains.
Bristol Myers Squibb Co. closed 1.43% short of its 52-week high of $68.64, which the company reached on August 19th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.48% to $275.21, Pfizer Inc. $(PFE)$ rose 1.65% to $29.02, and Abbott Laboratories $(ABT)$ rose 1.41% to $110.47.
Trading volume (7.7 M) remained 3.7 million below its 50-day average volume of 11.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.